# Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-08 22:29 UTC · Category: Business · Sources: 8 · Current Velocity: 5.66

## Intelligence Brief
"Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial" developed substantial multi-source reporting across the Business sector, tracked across 8 distinct newsrooms by Newsylist.


Key reporting was led by Yahoo, Clinical Trials Arena, firstwordpharma.com and AD HOC NEWS. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial?
Coverage spiked when 8 independent newsrooms published 8 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Yahoo | BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOTHRMd1RwclA5S25kOVY1b1ZKSU04ZW5fRTR0ODByalRQcEtPOThqMDRCQUplRjNrbUxxcUt6MGZMd0NVVW1HRTFnVW10S25LTWhIV2tVNXBMeU9TWDNqUW5hckVFQ2NlWFpnMjE4RnVSTUJwWGdkLXFvWHdVd2VRcEYyRk5JS1lXNDU4aVplSGRuVDRX?oc=5) |
| Clinical Trials Arena | BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMihwFBVV95cUxNVUJyeVliWjJwcGg2enpxcVZLR3Bub2cyaGRZcEpxV1pQY1JwSUp4MDQwWkl3cVpsTDk5WUlEV3JqQ3o2ci1mbk12VjV3UmNRMVJXejloRU9tWFlhUmxMdHBSajB5RUUxdlBEOTYzNGZrRTB1bTcwMXBQc1VMUzJGSDdsQk1JNHc?oc=5) |
| firstwordpharma.com | Next-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE0ydGZ2NXVEaGl0T3VzTzBVOFdlc053eVhZalpWNkZ3S3hjT1B1dmJmNnpjOEY2YUZTT2lzQkNUZl85WmhNYjN0TlVtQkJYeERtQjU4?oc=5) |
| AD HOC NEWS | Bristol Myers Squibb stock gains after trial success | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxPby1iSHpsbzBzVGFaS0RnQVM1c21VTDFHYmhVaTZzLUtQdGd4NkFvRVY3N1dPYldkLXltbDJPTFJ1YzJzWkV4RXg1MmNudzd3T0p2cnpUdktTYUgyVjY2N0xfZUdwaEF4bWtFdE1ZMHdIN1dTWFZXSGhLTS1tUXdxSGJfeUNXbVc5TGtSc1hJcDdhZkphdkN1cWhFVXdlNmhyaW5ESkJaQXVsdEFJTmlqSUhJZGpLdw?oc=5) |
| Oncodaily | Arlocabtagene Autoleucel Meets Primary Endpoint in Phase 2 QUINTESSENTIAL Trial for Multiple Myeloma | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMickFVX3lxTFBOMmhhLXl6STZzRXB1ZWFQVDFodm5hMHRBcjdaQm04T3JjV2oxdkJINmZuWXVQX0JMWm8xbWJlWTNCckdJNDZ2Mm5xeFJYR1Y1eFlTOWZCQWt4LTJkRk55eWFvaDg4VERZRzFVM3I5YXd1dw?oc=5) |
| onclive.com | Arlo-Cel Meets ORR End Point in BCMA-Pretreated, Quadruple-Class Exposed R/R Myeloma | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxPVTdrWHRQOWpMd18wYmttVHkzN0ZCYWFSSmdNZGRla3o5T2c5QzhZWmVZTGtRSE9yREl3cEszVFVEa09ENHMxaTl1Skw0X19aS0NNOWZtcnc5TGZKTzRnb2tobVNWdUVoWFVxM2Jlc053b0dJMm1NMUdsa29pVlFMNGFuNFh3Wk04RDd3RlVjRXZDRldXR1pPaTVVd0ZicWJLR3lpbmp5UndFQ0F6U3d0c2p3?oc=5) |
| Fierce Biotech | Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPNVQzak9pWHdSSVlpbHEyc29FczdmQUVmQjZ4OF96cHRWcEZQbDlGOEVHbElrNENXQW5iQTZKSEdBWVpvNU9zSFhaclR6b0xSUzVIQWFydDhWU3d1WTlaSk5ZcUZPRU9PS2lIa1BDS1JvT21BVnFJaFl3R2VQSVlCZ2VkZHBfdl8tN1lWTFNZZ3RfYUc0VDE0eEtaOFBKOFg4Sm1qOVE5MlRTMG5RNF9Z?oc=5) |
| reuters.com | Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial | 2026-09-08 13:10 | [Source Link](https://news.google.com/rss/articles/CBMi2wFBVV95cUxPangzOHZiUTJWRlJlVlhlWFFFNlduVURITDVFNnRDQW1DN1dZb05TSmtjd0dWM2ZPTm5MaG1PMkstbHQ0VXB5T0c3WGY0VVdoamRLeXZHc0RoRFMyNE44QVJZUGtaU0JReUw3VTZaMTMtUy01WlRiRXRqUVVMWTNYVzNZTnBaVllpM2NlNDI4S2VuR1RBRW9OdFowT3FzZkRYZDZWVDZTRmlKYUgxNmF0bThoYnhlRXhobGxTZnhQOFVSM0pvWDhfMU9GaDNJNDc2V0xVR192bERpN2M?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-08/bristol-myers-blood-cancer-cell-therapy-succeeds-in-mid-stage-trial*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*